1 – 15 of 85
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling
2024) In Cell Reports(
- Contribution to journal › Article
-
Mark
OSBP-mediated PI(4)P-cholesterol exchange at endoplasmic reticulum-secretory granule contact sites controls insulin secretion
(
- Contribution to journal › Article
-
Mark
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration
(
- Contribution to journal › Article
- 2023
-
Mark
A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD
(
- Contribution to journal › Article
-
Mark
Temporal multimodal single-cell profiling of native hematopoiesis illuminates altered differentiation trajectories with age
(
- Contribution to journal › Article
-
Mark
Shigella IpaA mediates actin bundling through diffusible vinculin oligomers with activation imprint
(
- Contribution to journal › Article
-
Mark
Defective peripheral B cell selection in common variable immune deficiency patients with autoimmune manifestations
(
- Contribution to journal › Article
-
Mark
Single-cell transcriptomics of human traumatic brain injury reveals activation of endogenous retroviruses in oligodendroglia
(
- Contribution to journal › Article
-
Mark
Autophagy-mediated control of ribosome homeostasis in oncogene-induced senescence
(
- Contribution to journal › Article
-
Mark
Nuclear factor Y is a pervasive regulator of neuronal gene expression
(
- Contribution to journal › Article
-
Mark
The molecular genetic landscape of human brain size variation
(
- Contribution to journal › Article
- 2022
-
Mark
Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction
(
- Contribution to journal › Article
-
Mark
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
(
- Contribution to journal › Article
-
Mark
Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway
(
- Contribution to journal › Article